The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
FOXP3+/CD8+ tumor-infiltrating T-cell ratio as a marker for pathologic response to induction therapy of non-small cell lung cancer.
Hiroyuki Tao
No relevant relationships to disclose
Kazuhiko Shien
No relevant relationships to disclose
Junichi Soh
No relevant relationships to disclose
Fumiho Sano
No relevant relationships to disclose
Tatsuro Hayashi
No relevant relationships to disclose
Hiromasa Yamamoto
No relevant relationships to disclose
Toshiki Tanaka
No relevant relationships to disclose
Eisuke Matsuda
No relevant relationships to disclose
Shinichi Toyooka
No relevant relationships to disclose
Kazunori Okabe
No relevant relationships to disclose
Kazurou Sugi
No relevant relationships to disclose
Shinichiro Miyoshi
No relevant relationships to disclose